Homma Kazuaki
Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
The Hugh Knowles Center for Clinical and Basic Science in Hearing and Its Disorders, Northwestern University, Evanston, IL 60608, USA.
Biomedicines. 2022 Sep 12;10(9):2254. doi: 10.3390/biomedicines10092254.
Deafness-associated genes (also associated with heart diseases) and (only associated with hearing loss) encode the homotetrameric voltage-gated potassium ion channels Kv7.1 and Kv7.4, respectively. To date, over 700 and over 70 variants have been identified in patients. The vast majority of these variants are inherited dominantly, and their pathogenicity is often explained by dominant-negative inhibition or haploinsufficiency. Our recent study unexpectedly identified cell-death-inducing cytotoxicity in several Kv7.1 and Kv7.4 variants. Elucidation of this cytotoxicity mechanism and identification of its modifiers (drugs) have great potential for aiding the development of a novel pharmacological strategy against many pathogenic variants. The purpose of this review is to disseminate this emerging pathological role of Kv7 variants and to underscore the importance of experimentally characterizing disease-associated variants.
与耳聋相关的基因(也与心脏病有关)和(仅与听力损失有关)分别编码同四聚体电压门控钾离子通道Kv7.1和Kv7.4。迄今为止,已在患者中鉴定出700多个和70多个变体。这些变体绝大多数是显性遗传的,其致病性通常由显性负抑制或单倍体不足来解释。我们最近的研究意外地在几种Kv7.1和Kv7.4变体中发现了诱导细胞死亡的细胞毒性。阐明这种细胞毒性机制并鉴定其修饰剂(药物)对于帮助开发针对许多致病变体的新型药理学策略具有巨大潜力。本综述的目的是传播Kv7变体这一新兴的病理作用,并强调对疾病相关变体进行实验表征的重要性。